Skip to main content


Leading Science for a Malaria-Free World 

Founded in May 2001 and continuously supported by Bloomberg Philanthropies, the Johns Hopkins Malaria Research Institute conducts discovery research at the Bloomberg School of Public Health in Baltimore and field research at the Macha Research Trust in Zambia and other sites of endemic malaria in sub-Saharan Africa, India, and elsewhere. 

The initial Bloomberg Philanthropies gift established a state-of-the-art research facility with the goal to treat and control malaria, develop a vaccine, and find new drug targets and innovative strategies to prevent and cure the deadly disease. The Institute has contributed to advances in all these areas and is one of the most comprehensive research endeavors focused on malaria globally.


World Malaria Day Symposium 2024

The symposium is on Thursday, April 25. It is a full-day, in-person, complimentary symposium, among North America's largest World Malaria Day events. Registration is now closed.  

News and Noteworthy


Innovation Advance | Dimopoulos Lab

The international team of researchers led by JHMRI Deputy Director George Dimopoulos with Professor Charles Wondji at the CRID in Cameroon worked with Hyris to develop a new, simple, portable device that delivers early, cost-effective detection of mosquito resistance to insecticides. 


Latest Research Advance| Jacob-Lorena Lab

Scientists weaponize the symbiotic bacteria in mosquitoes against the deadly diseases they transmit.

Applications Welcome

Two full-time, tenure-track faculty positions are open. Seeking candidates that use ‘omics’ technologies and systems biology approaches in their studies of the pathogen, the host, or vector.

Malaria Research in Action | A Video

Scientists at the Johns Hopkins Malaria Research Institute are working to better understand and fight malaria from the labs in Baltimore to the field in Southern and Central Africa.